Synthesis of a series of NAD+ analogues, potential inhibitors of PARP 1, using ADP conjugates functionalized at the terminal phosphate group


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

A convenient approach has been proposed to the synthesis of nicotinamide adenine dinucleotide (NAD+) mimetics, which comprise morpholino analogues of nucleosides. The approach is based on the use of ADP conjugates containing an amino group, which is tethered to the terminal phosphate through the aliphatic linker by the phosphodiester bond. We have synthesized four series of the NAD+ mimetics, which differ in the type of the modified nucleoside (2-aminomethylmorpholine (Mor) or 2-aminomethyl-4-carboxymethylmorpholine (MorGly) derivatives), in the linker length, and in the manner of the nucleoside attachment to the ADP derivative. We have studied the efficiency of NAD+ mimetics in the inhibition of the auto-poly(ADP-ribosyl)ation by the PARP 1 enzyme. The linker length, the mode of the attachment of the morpholino nucleoside analogue, and the nature of the heterocyclic base of the modified nucleoside were shown to inf luence the inhibition efficiency.

Sobre autores

Yu. Sherstyuk

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090

A. Zakharenko

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090

M. Kutuzov

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090

M. Sukhanova

Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University

Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630090

O. Lavrik

Institute of Chemical Biology and Fundamental Medicine; Novosibirsk State University

Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090; Novosibirsk, 630090

V. Silnikov

Institute of Chemical Biology and Fundamental Medicine

Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090

T. Abramova

Institute of Chemical Biology and Fundamental Medicine

Autor responsável pela correspondência
Email: abramova@niboch.nsc.ru
Rússia, Novosibirsk, 630090

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2017